Literature DB >> 30962220

Trisomy 21 Is a Cause of Permanent Neonatal Diabetes That Is Autoimmune but Not HLA Associated.

Matthew B Johnson1, Elisa De Franco1, Siri Atma W Greeley2, Lisa R Letourneau2, Kathleen M Gillespie3, Matthew N Wakeling1, Sian Ellard1, Sarah E Flanagan1, Kashyap A Patel1, Andrew T Hattersley4.   

Abstract

Identifying new causes of permanent neonatal diabetes (PNDM) (diagnosis <6 months) provides important insights into β-cell biology. Patients with Down syndrome (DS) resulting from trisomy 21 are four times more likely to have childhood diabetes with an intermediate HLA association. It is not known whether DS can cause PNDM. We found that trisomy 21 was seven times more likely in our PNDM cohort than in the population (13 of 1,522 = 85 of 10,000 observed vs. 12.6 of 10,000 expected) and none of the 13 DS-PNDM patients had a mutation in the known PNDM genes that explained 82.9% of non-DS PNDM. Islet autoantibodies were present in 4 of 9 DS-PNDM patients, but DS-PNDM was not associated with polygenic susceptibility to type 1 diabetes (T1D). We conclude that trisomy 21 is a cause of autoimmune PNDM that is not HLA associated. We propose that autoimmune diabetes in DS is heterogeneous and includes coincidental T1D that is HLA associated and diabetes caused by trisomy 21 that is not HLA associated.
© 2019 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2019        PMID: 30962220      PMCID: PMC6609990          DOI: 10.2337/db19-0045

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  39 in total

1.  Increased prevalence of Down's syndrome in individuals with type 1 diabetes in Denmark: A nationwide population-based study.

Authors:  R Bergholdt; S Eising; J Nerup; F Pociot
Journal:  Diabetologia       Date:  2006-03-31       Impact factor: 10.122

2.  High familial risk and genetic susceptibility in early onset childhood diabetes.

Authors:  Kathleen M Gillespie; Edwin A M Gale; Polly J Bingley
Journal:  Diabetes       Date:  2002-01       Impact factor: 9.461

Review 3.  Type I interferons (alpha/beta) in immunity and autoimmunity.

Authors:  Argyrios N Theofilopoulos; Roberto Baccala; Bruce Beutler; Dwight H Kono
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

4.  Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes.

Authors:  Christiane Winkler; Jan Krumsiek; Florian Buettner; Christof Angermüller; Eleni Z Giannopoulou; Fabian J Theis; Anette-Gabriele Ziegler; Ezio Bonifacio
Journal:  Diabetologia       Date:  2014-09-04       Impact factor: 10.122

Review 5.  Update on Aire and thymic negative selection.

Authors:  Geraldo A Passos; Cesar A Speck-Hernandez; Amanda F Assis; Daniella A Mendes-da-Cruz
Journal:  Immunology       Date:  2017-09-26       Impact factor: 7.397

6.  UBASH3A Mediates Risk for Type 1 Diabetes Through Inhibition of T-Cell Receptor-Induced NF-κB Signaling.

Authors:  Yan Ge; Taylor K Paisie; Jeremy R B Newman; Lauren M McIntyre; Patrick Concannon
Journal:  Diabetes       Date:  2017-06-12       Impact factor: 9.461

7.  Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis.

Authors:  G Thomson; A M Valdes; J A Noble; I Kockum; M N Grote; J Najman; H A Erlich; F Cucca; A Pugliese; A Steenkiste; J S Dorman; S Caillat-Zucman; R Hermann; J Ilonen; A P Lambert; P J Bingley; K M Gillespie; A Lernmark; C B Sanjeevi; K S Rønningen; D E Undlien; E Thorsby; A Petrone; R Buzzetti; B P C Koeleman; B O Roep; G Saruhan-Direskeneli; F A Uyar; H Günoz; C Gorodezky; C Alaez; B O Boehm; W Mlynarski; H Ikegami; M Berrino; M E Fasano; E Dametto; S Israel; C Brautbar; A Santiago-Cortes; T Frazer de Llado; J-X She; T L Bugawan; J I Rotter; L Raffel; A Zeidler; F Leyva-Cobian; B R Hawkins; S H Chan; L Castano; F Pociot; J Nerup
Journal:  Tissue Antigens       Date:  2007-08

8.  HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families.

Authors:  H A Erlich; A Zeidler; J Chang; S Shaw; L J Raffel; W Klitz; Y Beshkov; G Costin; S Pressman; T Bugawan
Journal:  Nat Genet       Date:  1993-04       Impact factor: 38.330

9.  Early-onset, coexisting autoimmunity and decreased HLA-mediated susceptibility are the characteristics of diabetes in Down syndrome.

Authors:  Rachel J Aitken; Kay L Mehers; Alistair J Williams; Jamie Brown; Polly J Bingley; Reinhard W Holl; Tilman R Rohrer; Edith Schober; Majedah M Abdul-Rasoul; Julian P H Shield; Kathleen M Gillespie
Journal:  Diabetes Care       Date:  2012-12-28       Impact factor: 19.112

10.  Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes.

Authors:  Jeffrey C Barrett; David G Clayton; Patrick Concannon; Beena Akolkar; Jason D Cooper; Henry A Erlich; Cécile Julier; Grant Morahan; Jørn Nerup; Concepcion Nierras; Vincent Plagnol; Flemming Pociot; Helen Schuilenburg; Deborah J Smyth; Helen Stevens; John A Todd; Neil M Walker; Stephen S Rich
Journal:  Nat Genet       Date:  2009-05-10       Impact factor: 38.330

View more
  10 in total

1.  Mutations and variants of ONECUT1 in diabetes.

Authors:  Anne Philippi; Sandra Heller; Ivan G Costa; Valérie Senée; Marc Nicolino; Cécile Julier; Alexander Kleger; Markus Breunig; Zhijian Li; Gino Kwon; Ronan Russell; Anett Illing; Qiong Lin; Meike Hohwieler; Anne Degavre; Pierre Zalloua; Stefan Liebau; Michael Schuster; Johannes Krumm; Xi Zhang; Ryan Geusz; Jacqueline R Benthuysen; Allen Wang; Joshua Chiou; Kyle Gaulton; Heike Neubauer; Eric Simon; Thomas Klein; Martin Wagner; Gopika Nair; Céline Besse; Claire Dandine-Roulland; Robert Olaso; Jean-François Deleuze; Bernhard Kuster; Matthias Hebrok; Thomas Seufferlein; Maike Sander; Bernhard O Boehm; Franz Oswald
Journal:  Nat Med       Date:  2021-10-18       Impact factor: 87.241

Review 2.  Regulator of Calcineurin (RCAN): Beyond Down Syndrome Critical Region.

Authors:  Sun-Kyung Lee; Joohong Ahnn
Journal:  Mol Cells       Date:  2020-08-31       Impact factor: 5.034

3.  Identification of GCK-maturity-onset diabetes of the young in cases of neonatal hyperglycemia: A case series and review of clinical features.

Authors:  Alice E Hughes; Elisa De Franco; Evgenia Globa; Nataliya Zelinska; Dörte Hilgard; Popi Sifianou; Andrew T Hattersley; Sarah E Flanagan
Journal:  Pediatr Diabetes       Date:  2021-06-10       Impact factor: 3.409

4.  YIPF5 mutations cause neonatal diabetes and microcephaly through endoplasmic reticulum stress.

Authors:  Elisa De Franco; Maria Lytrivi; Hazem Ibrahim; Hossam Montaser; Matthew N Wakeling; Federica Fantuzzi; Kashyap Patel; Céline Demarez; Ying Cai; Mariana Igoillo-Esteve; Cristina Cosentino; Väinö Lithovius; Helena Vihinen; Eija Jokitalo; Thomas W Laver; Matthew B Johnson; Toshiaki Sawatani; Hadis Shakeri; Nathalie Pachera; Belma Haliloglu; Mehmet Nuri Ozbek; Edip Unal; Ruken Yıldırım; Tushar Godbole; Melek Yildiz; Banu Aydin; Angeline Bilheu; Ikuo Suzuki; Sarah E Flanagan; Pierre Vanderhaeghen; Valérie Senée; Cécile Julier; Piero Marchetti; Decio L Eizirik; Sian Ellard; Jonna Saarimäki-Vire; Timo Otonkoski; Miriam Cnop; Andrew T Hattersley
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

Review 5.  Stress Responses in Down Syndrome Neurodegeneration: State of the Art and Therapeutic Molecules.

Authors:  Chiara Lanzillotta; Fabio Di Domenico
Journal:  Biomolecules       Date:  2021-02-11

6.  Comprehensive phenotypic analysis of the Dp1Tyb mouse strain reveals a broad range of Down syndrome-related phenotypes.

Authors:  Eva Lana-Elola; Heather Cater; Sheona Watson-Scales; Simon Greenaway; Jennifer Müller-Winkler; Dorota Gibbins; Mihaela Nemes; Amy Slender; Tertius Hough; Piia Keskivali-Bond; Cheryl L Scudamore; Eleanor Herbert; Gareth T Banks; Helene Mobbs; Tara Canonica; Justin Tosh; Suzanna Noy; Miriam Llorian; Patrick M Nolan; Julian L Griffin; Mark Good; Michelle Simon; Ann-Marie Mallon; Sara Wells; Elizabeth M C Fisher; Victor L J Tybulewicz
Journal:  Dis Model Mech       Date:  2021-10-15       Impact factor: 5.732

7.  Endocrinal dysfunction in children with Down syndrome.

Authors:  Kotb Abbass Metwalley; Hekma Saad Farghaly
Journal:  Ann Pediatr Endocrinol Metab       Date:  2022-03-31

8.  Increased referrals for congenital hyperinsulinism genetic testing in children with trisomy 21 reflects the high burden of non-genetic risk factors in this group.

Authors:  Thomas I Hewat; Thomas W Laver; Jayne A L Houghton; Jonna M E Männistö; Sabah Alvi; Stephen P Brearey; Declan Cody; Antonia Dastamani; Miguel De Los Santos La Torre; Nuala Murphy; Birgit Rami-Merhar; Birgit Wefers; Hanna Huopio; Indraneel Banerjee; Matthew B Johnson; Sarah E Flanagan
Journal:  Pediatr Diabetes       Date:  2022-03-23       Impact factor: 3.409

Review 9.  Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions.

Authors:  Mara Dierssen; Marta Fructuoso; María Martínez de Lagrán; Marzia Perluigi; Eugenio Barone
Journal:  Front Neurosci       Date:  2020-07-08       Impact factor: 4.677

10.  Type 1 diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta cells.

Authors:  Matthew B Johnson; Kashyap A Patel; Elisa De Franco; William Hagopian; Michael Killian; Timothy J McDonald; Timothy I M Tree; Clara Domingo-Vila; Michelle Hudson; Suzanne Hammersley; Rebecca Dobbs; Sian Ellard; Sarah E Flanagan; Andrew T Hattersley; Richard A Oram
Journal:  Diabetologia       Date:  2020-10-08       Impact factor: 10.122

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.